Showdown Near Between Brazil and AIDS Drugs Labs

The Brazilian government must soon decide about breaking the patents of three antiretroviral medications that are part of the anti-AIDS cocktail.

The decision will probably be made as soon as Minister of Health, Humberto Costa, returns from his trip to Africa, where he is accompanying President Luiz Inácio Lula da Silva.


During this week, the Ministry will still try to negotiate with medicine producers who, almost a month ago, received a government’s request asking for their voluntary license consent, and authorization for the government to produce the medications in Brazil paying for their royalties.


Without identifying the laboratories, the Minister press-service informed that their answers were not very positive. Two out of the three labs contacted by the Minister accept to negotiate, but not under the government’s terms, and the third one does not agree with the proposal.


According to the secretary of Health Protection, Jarbas Barbosa, the volume of resources Brazil spends buying antiretrovirals increases to “unbearable” levels. In 2004, the Ministry spent US$ 217 million (560 million reais) with this type of medication.


According to Barbosa, the government will spend over R$ 349 million (900 million reais) this year, even though the number of new patients has risen only 20%.


“Looking ahead, in two or three years, the situation may negatively affect Brazilian policy for universal access to antiretroviral medication,” he alerts.


Brazil produces only eight of the 16 medications that integrate the anti-AIDS cocktail.


Last March 14th, the Ministry solicited voluntary licensing of three medications: Lopinavir /Ritonavir (Abbot), Efavirenz (Merck Sharp & Dohme), and Tenofovir (Gilead Science Incorporation).


The Ministry of Health affirms that if the laboratories do not accept the proposal, the country may seek compulsory licensing. This mechanism is allowed by the Trade-Related Aspects of Intellectual Property Rights (TRIPS) for cases involving public health.


Agência Brasil

Tags:

You May Also Like

Brazil Gets US$ 1.3 Billion from World Bank for Environment Control

Brazil is going to get an US$ 1.3 billion loan from the World Bank ...

56% of College Students in Brazil Are Women. Bad Sign, Says Expert.

Over the course of 13 years, in Brazil, the number of women enrolled in ...

Brazil: Minimum Wage Goes to Committee

Brazilian President Luiz Inácio Lula da Silva wants a committee to discuss and present ...

Brazil’s New Finance Czar Goes to War Against Inflation and High Interests

Brazil’s new Economy Minister, Guido Mantega, said that Brazil needs "civilized interest rates" signaling ...

Vatican Confirms: Pope Will Visit Brazil in May

Pope Benedict XVI will visit Brazil in May 2007. The news was confirmed by  ...

In Piracy, Brazil Is in Good Company: China, Russia and Turkey

European Union business organizations claim that Brazil, Argentina, Chile and Paraguay are among the ...

Led by Industry Brazil’s GDP Grows 5.3% This Year

Brazil's Gross Domestic Product (GDP), i.e. the sum of all goods and services produced ...

Brazil’s Varig Flies into Bankruptcy Skies

Varig (Viação Aérea Rio-Grandense), the troubled Brazilian airline, which is the largest Latin America ...

Brazil’s Big Contractors Looking for a Bigger Slice of Belo Monte’s Action

A sweetheart deal? Maybe. After all, the Brazilian Development Bank (BNDES) will ante up ...

Brazil’s Daylight Savings Time Starts in October and Will Save 5% in Electricity

Brazil’s Ministry of Mines and Energy has announced that daylight savings time in Brazil ...